HIV-1 Escapes CTLs Specific for Cryptic Epitope
Author Information
Author(s): Cardinaud Sylvain, Consiglieri Gesa, Bouziat Romain, Urrutia Alejandra, Graff-Dubois Stéphanie, Fourati Slim, Malet Isabelle, Guergnon Julien, Guihot Amélie, Katlama Christine, Autran Brigitte, van Endert Peter, Lemonnier François A., Appay Victor, Schwartz Olivier, Kloetzel Peter M., Moris Arnaud
Primary Institution: INSERM, UMR-S945, Université Pierre et Marie Curie (UPMC), Paris, France
Hypothesis
HIV-1 can escape CTL surveillance by introducing mutations that lead to the destruction of cryptic epitopes by proteasomes.
Conclusion
The study demonstrates that a single amino acid substitution in the HIV-1 epitope can lead to its destruction and prevent CTL activation.
Supporting Evidence
- Proviruses encoding Q9VF/5D were significantly less represented in HLA-B*07+ patients.
- 16% of HLA-B*07+ patients exhibited CTL responses targeting Q9VF epitopes.
- Q9VF/5N substitution introduces a strong proteasomal cleavage site, reducing epitope production.
Takeaway
HIV can change a tiny part of itself to hide from the body's defenses, making it harder for the immune system to fight it off.
Methodology
The study involved sequencing HIV proviral DNA from patients and analyzing CTL responses to different HIV-1 epitope variants.
Potential Biases
Potential biases may arise from the selection of patients and the specific HLA types studied.
Limitations
The study was limited to a specific cohort of HIV-infected individuals and may not be generalizable to all populations.
Participant Demographics
The study included HIV-infected patients with varying HLA-B*07 status.
Statistical Information
P-Value
p<0.04
Statistical Significance
p<0.04
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website